CORREN, J. .; SZEFLER, S. J. .; SHER, E. .; KORENBLAT, P. .; SOONG, W. .; HANANIA, N. A. .; BERMAN, G. .; BRUSSELLE, G. .; ZITNIK, R. .; NATALIE, C. R. .; SIU, K. .; WU, W.-S. .; QIAO, M. .; LIO, P. .; ARMSTRONG, A. W. . Post-Hoc Analyses Support Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Uncontrolled Eosinophilic Asthma and Prior Exacerbations. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 1, p. s524, 2025. DOI: 10.25251/skin.9.supp.524. Disponível em: https://skin.dermsquared.com/skin/article/view/3148. Acesso em: 12 mar. 2025.